Fig. 6From: Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?Novel radionuclides used by end users in their daily routine (green) and radionuclides that respondents would be interested to use in the next 2–5 years (blue)Back to article page